Abakumova, T.; Kuzkina, A.; Koshkin, P.; Pozdeeva, D.; Abakumov, M.; Melnikov, P.; Ionova, K.; Gubskii, I.; Gurina, O.; Nukolova, N.; Chekhonin, V. Localized Increased Permeability of Blood–Brain Barrier for Antibody Conjugates in the Cuprizone Model of Demyelination. Int. J. Mol. Sci.2023, 24, 12688.
Abakumova, T.; Kuzkina, A.; Koshkin, P.; Pozdeeva, D.; Abakumov, M.; Melnikov, P.; Ionova, K.; Gubskii, I.; Gurina, O.; Nukolova, N.; Chekhonin, V. Localized Increased Permeability of Blood–Brain Barrier for Antibody Conjugates in the Cuprizone Model of Demyelination. Int. J. Mol. Sci. 2023, 24, 12688.
Abakumova, T.; Kuzkina, A.; Koshkin, P.; Pozdeeva, D.; Abakumov, M.; Melnikov, P.; Ionova, K.; Gubskii, I.; Gurina, O.; Nukolova, N.; Chekhonin, V. Localized Increased Permeability of Blood–Brain Barrier for Antibody Conjugates in the Cuprizone Model of Demyelination. Int. J. Mol. Sci.2023, 24, 12688.
Abakumova, T.; Kuzkina, A.; Koshkin, P.; Pozdeeva, D.; Abakumov, M.; Melnikov, P.; Ionova, K.; Gubskii, I.; Gurina, O.; Nukolova, N.; Chekhonin, V. Localized Increased Permeability of Blood–Brain Barrier for Antibody Conjugates in the Cuprizone Model of Demyelination. Int. J. Mol. Sci. 2023, 24, 12688.
Abstract
Development of new neurotherapeutics is strongly depending on appropriate animal model chosen in preclinical studies. A cuprizone model is an effective tool for studying demyelination and re-myelination processes in the brain, but BBB integrity in cuprizone model is still a topic for debate. Several publications claim that BBB remains intact during cuprizone-induced demyelination; others demonstrate results that could be explained by the increased BBB permeability. In our work we aim to analyze permeability of BBB for different macromolecules, particularly, antibody-conjugates in cuprizone-intoxicated mice. We compared the traditional approach using Evans blue injection with following dye extraction and detection of antibody-conjugates using magnetic resonance imaging (MRI) and confocal microscopy to analyze BBB permeability in cuprizone model. First, we validated our model of demyelination by detecting changes in gene expression of myelin basic protein and proteolipid protein, and by performing MRI and histological analysis. Our results suggest that the methods with better sensitivity were able to detect the accumulation of macromolecules (such as fluorescent-labeled or gadolinium-labeled antibody conjugates) in the brain, suggesting a local BBB disruption in the demyelinating area. These findings support previous investigations that ques-tioned BBB integrity in cuprizone model and demonstrate possibility for delivery of anti-body-conjugates to demyelinated corpus callosum
Keywords
cuprizone, BBB permeability, demyelination, antibody conjugates, Gd-DTPA, MRI, Evans Blue
Subject
Biology and Life Sciences, Neuroscience and Neurology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.